Capital World Investors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,262,798
Closed -$123M 558
2015
Q1
$123M Buy
1,262,798
+230,100
+22% +$22.4M 0.03% 284
2014
Q4
$95.8M Buy
1,032,698
+89,000
+9% +$8.26M 0.03% 302
2014
Q3
$64.9M Hold
943,698
0.02% 344
2014
Q2
$98.9M Sell
943,698
-84,700
-8% -$8.88M 0.03% 311
2014
Q1
$85.3M Buy
1,028,398
+483,698
+89% +$40.1M 0.02% 308
2013
Q4
$35.3M Buy
544,700
+14,700
+3% +$951K 0.01% 369
2013
Q3
$33.6M Buy
530,000
+305,000
+136% +$19.3M 0.01% 374
2013
Q2
$9.45M Buy
+225,000
New +$9.45M ﹤0.01% 438